- Report of Foreign Issuer (6-K)
16 January 2009 - 2:45AM
Edgar (US Regulatory)
FORM 6-K
U.S.
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES
EXCHANGE ACT OF 1934
dated January 15, 2009
Commission File Number 0-51373
CHEMGENEX PHARMACEUTICALS LIMITED
(Exact Name as Specified
in its Charter)
N/A
(Translation of
Registrants Name)
Level 4,199 Moorabool Street
Geelong 3220, Victoria
Australia
(Address of principal
executive offices)
Indicate by check
mark whether the registrant files or will file annual reports under cover of Form 20-F
or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1):
o
Indicate by check
mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7):
o
Indicate by check
mark whether by furnishing the information contained in this Form, the
registrant is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
o
No
x
If Yes is
marked, indicate below the file number assigned to the registrant in connection
with Rule 12g3-2(b): Not
applicable.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused the Report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Date: January 15,
2009
|
CHEMGENEX
PHARMACEUTICALS
LIMITED
|
|
|
|
|
|
By:
|
/s/ Greg R. Collier
|
|
|
Name:
|
Greg R. Collier
|
|
|
Title:
|
Managing Director
|
2
EXHIBIT INDEX
Exhibit
|
|
Description
|
|
|
|
99.1
|
|
Release,
January 14, 2009
|
|
|
|
99.2
|
|
Corporate
presentation January 2009
|
3
Chemgenex (NASDAQ:CXSP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Chemgenex (NASDAQ:CXSP)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Chemgenex Pharmaceuticals Ltd (MM) (NASDAQ): 0 recent articles
More News Articles